GlassScriptPhysician profile
Jennifer N Weber
NPI 1043656952
$12,365.14
in general payments reported to CMS, 2019-2025
47 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,804 · 2020: $1,485 · 2021: $2,054 · 2022: $2,309 · 2023: $2,318 · 2024: $1,384 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,712.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,315.56 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,981.02 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $862.82 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $779.11 | 2019-2024 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $755.89 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $715.76 | 2019-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $590.13 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $585.19 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $564.28 | 2019-2025 | Jardiance, Ofev |
| Janssen Pharmaceuticals, INC | $386.88 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $372.53 | 2019-2023 | Steglujan, Steglatro, Belsomra |
| Allergan, INC. | $242.46 | 2019-2020 | |
| Amarin Pharma, INC. | $241.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $213.21 | 2022-2025 | |
| Corium, LLC | $138.51 | 2022-2024 | Azstarys |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.